遗传检测指南改善先天性心脏病新生儿的诊疗
该回顾性横断面研究纳入664例住院先天性心脏病(CHD)新生儿,分析遗传检测指南实施前后的检测实践。指南于2014年实施后,遗传检测率从2013年的40%升至2018年的75%(OR 5.02,95%CI 2.84-8.88,P<.001),遗传学家参与率从24%升至64%(P<.001),检测阳性率保持42%且跨年份和亚型一致,每年估计额外增加10例遗传诊断(增幅29%)。
要点
- CHD新生儿遗传检测阳性率高(42%),且在不同年份和患者亚型中保持一致。
- 实施机构遗传检测指南后,检测率显著提高并转向染色体微阵列、基因面板和外显子组测序等新方法。
- 检测增加带来每年约10例额外遗传诊断(增幅29%),可能影响患者管理。
核心结论
- 在CHD新生儿中遗传检测阳性率高,实施指南后检测率显著增加并转向基于测序的新方法,增加检测可发现更多具有临床意义的结果并可能影响患者诊疗。
研究设计与样本
- 回顾性横断面研究,纳入664例住院CHD新生儿,采用多变量分析评估不同时间和患者亚型间的遗传检测实践。
主要发现
- 遗传检测率从2013年的40%升至2018年的75%(OR 5.02,95%CI 2.84-8.88,P<.001)。
- 医学遗传学家参与率从2013年的24%升至2018年的64%(P<.001)。
- 2018年染色体微阵列(P<.001)、基因面板(P=.016)和外显子组测序(P=.001)的使用增加。
- 检测阳性率为42%,在不同年份和患者亚型中保持一致。
- 检测率增加(P<.001)而阳性率不变(P=.139),估计每年额外增加10例遗传诊断,增幅29%。
临床怎么用
- 对住院CHD新生儿应实施机构遗传检测指南以提高检测率,并优先采用染色体微阵列、基因面板和外显子组测序等新方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate genetic evaluation practices in newborns with the most common birth defect, congenital heart defects (CHD), we determined the prevalence and the yield of genetic evaluation across time and across patient subtypes, before and after implementation of institutional genetic testing guidelines. STUDY DESIGN: This was a retrospective, cross-sectional study of 664 hospitalized newborns with CHD using multivariate analyses of genetic evaluation practices across time and patient subtypes. RESULTS: Genetic testing guidelines for hospitalized newborns with CHD were implemented in 2014, and subsequently genetic testing increased (40% in 2013 and 75% in 2018, OR 5.02, 95% CI 2.84-8.88, P < .001) as did medical geneticists' involvement (24% in 2013 and 64% in 2018, P < .001). In 2018, there was an increased use of chromosomal microarray (P < .001), gene panels (P = .016), and exome sequencing (P = .001). The testing yield was high (42%) and consistent across years and patient subtypes analyzed. Increased testing prevalence (P < .001) concomitant with consistent testing yield (P = .139) added an estimated 10 additional genetic diagnoses per year, reflecting a 29% increase. CONCLUSIONS: In patients with CHD, yield of genetic testing was high. After implementing guidelines, genetic testing increased significantly and shifted to newer sequence-based methods. Increased use of genetic testing identified more patients with clinically important results with potential to impact patient care.
引用
- Durbin MD, Fairman K, Helvaty LR, et al. Genetic Testing Guidelines Impact Care in Newborns with Congenital Heart Defects. J Pediatr. 2023. PMID: 37211210. doi:10.1016/j.jpeds.2023.113495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。